Innovaccer Launches Flow Capture, Bringing Autonomous Coding to the Frontlines of American Healthcare Innovaccer, the leading healthcare AI company, launched Flow Capture, an autonomous medical coding solution designed to eliminate one of the most persistent bottlenecks in American healthcare: manual…
Fierce Healthcare Names SpotitEarly a “Fierce 15” Company of 2026 SpotitEarly, a multi-cancer early detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples, today announced that Fierce Healthcare has named it as one…
New Real-World Evidence Study Shows Leva® Pelvic Health System Significantly Improves Fecal Incontinence Symptoms in Women Axena Health, Inc., a women’s health company redefining the standard of care for pelvic health through clinically proven, non-invasive treatments, today announced the publication of a…
NRC Health Announces $60 Million Share Repurchase Authorization National Research Corporation, doing business as NRC Health, has announced that its Board of Directors has approved a new stock repurchase program that allows the company to buy back up to $60…
Anthem, Athens Orthopedic Clinic Partner to Expand Orthopedic Access in Northeast Georgia Anthem Blue Cross and Blue Shield of Georgia has entered into a strategic partnership with Athens Orthopedic Clinic to broaden access to orthopedic services for patients across Northeast…
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® GoodRx the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound® (tirzepatide) KwikPen® (for single-patient-use) through GoodRx Employer Direct. As one of Lilly’s Employer Connect independent program administrators, GoodRx…
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era MindWalk Holdings Corp. a bio-native AI company, today announced B Cell Llama™, a platform for the discovery of VHH nanobodies: the single-domain antibody fragments…
Lone Star Funds Signs Agreement to Buy Lonza’s Capsules and Health Ingredients Division Lone Star Funds has announced a major strategic investment through an agreement to acquire the Capsules & Health Ingredients (CHI) business from Lonza Group AG, marking a…
Savara Provides Regulatory Update on MOLBREEVI Development Program for Autoimmune Pulmonary Alveolar Proteinosis Savara clinical-stage biopharmaceutical company focused on developing treatments for rare respiratory diseases, has announced a significant regulatory update regarding its investigational therapy MOLBREEVI, which is being developed…
FDA Greenlights Sotyktu to Treat Active Psoriatic Arthritis in Adults The U.S. Food and Drug Administration (FDA) has approved Sotyktu (deucravacitinib), developed by Bristol Myers Squibb, for the treatment of adults living with Psoriatic Arthritis (PsA). This approval introduces a…
Liberate Bio Secures Myeloid-Optimized CAR Design Licenses to Advance In Vivo CAR-M Programs Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, announces that it has secured exclusive and non-exclusive licenses to…
Parabilis Medicines Reports Early Clinical Evidence that Zolucatetide Reduces Polyp Burden in a Patient with Familial Adenomatous Polyposis Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicon™ peptide platform to…